Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of OphtAI Software Diagnostic Performance for Automated Screening of Diabetic Retinopathy, Diabetic Macular Edema, Glaucoma, ARM and ARMD: a Multicentre Study

NCT05752045 is registered in ClinicalTrials.gov with Evolucare Technologies as lead sponsor.

NCT NCT05752045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05752045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of OphtAI Software Diagnostic Performance for Automated Screening of Diabetic Retinopathy, Diabetic Macular Edema, Glaucoma, ARM and ARMD: a Multicentre Study
Lead sponsor
Evolucare Technologies
Phase
Not applicable
Overall status
Unknown status
Start date
June 28, 2023
Completion date
March 31, 2024
Enrollment
1,389 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, age-related maculopathy, diabetic macular edema, diabetic retinopathy, glaucoma